A detailed history of Gables Capital Management Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Gables Capital Management Inc. holds 956 shares of ZTS stock, worth $167,940. This represents 0.1% of its overall portfolio holdings.

Number of Shares
956
Previous 956 -0.0%
Holding current value
$167,940
Previous $165,000 12.73%
% of portfolio
0.1%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 03, 2021

BUY
$157.07 - $174.35 $157 - $174
1 Added 0.1%
956 $158,000
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $137 - $165
-1 Reduced 0.1%
955 $158,000
Q2 2020

Jul 30, 2020

SELL
$111.92 - $142.53 $33,016 - $42,046
-295 Reduced 23.58%
956 $131,000
Q4 2019

Feb 10, 2020

SELL
$116.25 - $133.25 $5,696 - $6,529
-49 Reduced 3.77%
1,251 $166,000
Q1 2018

May 17, 2018

BUY
$71.51 - $84.69 $92,963 - $110,097
1,300 New
1,300 $109,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Gables Capital Management Inc. Portfolio

Follow Gables Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.